Medical cannabis company AusCann Group Holdings has appointed international pharmaceutical executive Ido Kanyon as its new chief executive, nearly five months after it was announced that Elaine Darby would resign from the role.
Elaine Darby has advised AusCann Group Holdings of her intention to step down as managing director as the company transitions from a startup, focused on licensing and product development, to a phar
AusCann Group Holdings has today announced two board changes, with managing director Elaine Darby advising of her resignation and pharmaceutical executive Paul MacLeman appointed as executive director.
Joondalup-based medicinal cannabis hopeful AusCann Holdings has secured $33.4 million from local and North American institutions, with NYSE-listed marijuana play Canopy Growth Corporation upping its stake to 11.2 per cent.
The chief executive of medical cannabis company AusCann Group Holdings has received a boost to her salary package, which will net her about $360,000 in cash for FY17.
The directors of medicinal cannabis companies Creso Pharma and AusCann Group Holdings have reaped windfall gains worth $13 million after the vesting of performance rights and performance shares.
Perth company AusCann Group Holdings has become the seventh applicant to gain regulatory approval to cultivate medicinal cannabis in Australia, with the news lifting its share price by 17 per cent today.
Murdoch University has partnered with a Perth company which plans to use cannabis as a medicinal product, a day after scientists from the University of Western Australia said cannabis use could damage a person's DNA.
Shares in TW Holdings slumped sharply today after it announced a backdoor listing of medical cannabis company AusCann Group Holdings, the second deal of this type involving members of the Washer family.
